BRIGHT MINDS BIOSCIENCES INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
SEC Category Emerging growth company
State of Incorporation British Columbia, Canada
Business Address 19 VESTRY STREET, NEW YORK, NY, 10013
Mailing Address 19 VESTRY STREET, NEW YORK, NY, 10013
Phone 6474072515
Fiscal Year End 0930
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 6, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 9, 2026 | View on SEC |
| 6-K Foreign company current report | January 9, 2026 | View on SEC |
| 6-K Foreign company current report | January 9, 2026 | View on SEC |
| 6-K Foreign company current report | January 8, 2026 | View on SEC |
| 6-K Foreign company current report | January 7, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 7, 2026 | View on SEC |
| 6-K Foreign company current report | January 7, 2026 | View on SEC |
| 6-K Foreign company current report | January 6, 2026 | View on SEC |
Annual Reports
40-F December 23, 2025
- BRIGHT MINDS BIOSCIENCES INC. (DRUG) concluded its fiscal year on September 30, 2025.
- The company reported 7,635,789 common shares outstanding as of the fiscal year-end.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.